鉴定SARS-CoV-2 Mpro靶点有前途的抑制剂的计算机研究

IF 1.9 4区 医学 Q3 CHEMISTRY, MEDICINAL Medicinal Chemistry Pub Date : 2023-01-01 DOI:10.2174/1573406419666230413112802
V Alagarsamy, P Shyam Sundar, B Narendhar, M T Sulthana, Vishaka S Kulkarni, A Dharshini Aishwarya, V Raja Solomon, S Murugesan, S Jubie, K Rohitha, Sangeeta Dhanwar
{"title":"鉴定SARS-CoV-2 Mpro靶点有前途的抑制剂的计算机研究","authors":"V Alagarsamy,&nbsp;P Shyam Sundar,&nbsp;B Narendhar,&nbsp;M T Sulthana,&nbsp;Vishaka S Kulkarni,&nbsp;A Dharshini Aishwarya,&nbsp;V Raja Solomon,&nbsp;S Murugesan,&nbsp;S Jubie,&nbsp;K Rohitha,&nbsp;Sangeeta Dhanwar","doi":"10.2174/1573406419666230413112802","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and development and a substantial financial commitment, which is not achievable in the face of the current epidemic.</p><p><strong>Objective: </strong>This study aims to discover and recognize the most effective and promising small molecules by interacting SARS-CoV-2 M<sup>pro</sup> target through computational screening of 39 phytochemicals from five different Ayurvedic medicinal plants.</p><p><strong>Methods: </strong>The phytochemicals were downloaded from Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) PubChem, and the SARS-CoV-2 protein (PDB ID: 6LU7; M<sup>pro</sup>) was taken from the PDB. The molecular interactions, binding energy, and ADMET properties were analyzed.</p><p><strong>Results: </strong>The binding affinities were studied using a structure-based drug design of molecular docking, divulging 21 molecules possessing greater to equal affinity towards the target than the reference standard. Molecular docking analysis identified 13 phytochemicals, sennoside-B (-9.5 kcal/mol), isotrilobine (-9.4 kcal/mol), trilobine (-9.0 kcal/mol), serratagenic acid (-8.1 kcal/mol), fistulin (-8.0 kcal/mol), friedelin (-7.9 kcal/mol), oleanolic acid (-7.9 kcal/mol), uncinatone (-7.8 kcal/mol), 3,4-di- O-caffeoylquinic acid (-7.4 kcal/mol), clemaphenol A (-7.3 kcal/mol), pectolinarigenin (-7.2 kcal/mol), leucocyanidin (-7.2 kcal/mol), and 28-acetyl botulin (-7.2 kcal/mol) from ayurvedic medicinal plants phytochemicals possess greater affinity than the reference standard Molnupiravir (-7.0 kcal/mol) against SARS-CoV-2-M<sup>pro</sup>.</p><p><strong>Conclusion: </strong>Two molecules, namely sennoside-B, and isotrilobine with low binding energies, were predicted as most promising. Furthermore, we carried out molecular dynamics simulations for the sennoside-B protein complexes based on the docking score. ADMET properties prediction confirmed that the selected docked phytochemicals were optimal. These compounds can be investigated further and utilized as a parent core molecule to create novel lead molecules for preventing COVID-19.</p>","PeriodicalId":18382,"journal":{"name":"Medicinal Chemistry","volume":"19 9","pages":"925-938"},"PeriodicalIF":1.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M<sup>pro</sup> Target.\",\"authors\":\"V Alagarsamy,&nbsp;P Shyam Sundar,&nbsp;B Narendhar,&nbsp;M T Sulthana,&nbsp;Vishaka S Kulkarni,&nbsp;A Dharshini Aishwarya,&nbsp;V Raja Solomon,&nbsp;S Murugesan,&nbsp;S Jubie,&nbsp;K Rohitha,&nbsp;Sangeeta Dhanwar\",\"doi\":\"10.2174/1573406419666230413112802\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and development and a substantial financial commitment, which is not achievable in the face of the current epidemic.</p><p><strong>Objective: </strong>This study aims to discover and recognize the most effective and promising small molecules by interacting SARS-CoV-2 M<sup>pro</sup> target through computational screening of 39 phytochemicals from five different Ayurvedic medicinal plants.</p><p><strong>Methods: </strong>The phytochemicals were downloaded from Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) PubChem, and the SARS-CoV-2 protein (PDB ID: 6LU7; M<sup>pro</sup>) was taken from the PDB. The molecular interactions, binding energy, and ADMET properties were analyzed.</p><p><strong>Results: </strong>The binding affinities were studied using a structure-based drug design of molecular docking, divulging 21 molecules possessing greater to equal affinity towards the target than the reference standard. Molecular docking analysis identified 13 phytochemicals, sennoside-B (-9.5 kcal/mol), isotrilobine (-9.4 kcal/mol), trilobine (-9.0 kcal/mol), serratagenic acid (-8.1 kcal/mol), fistulin (-8.0 kcal/mol), friedelin (-7.9 kcal/mol), oleanolic acid (-7.9 kcal/mol), uncinatone (-7.8 kcal/mol), 3,4-di- O-caffeoylquinic acid (-7.4 kcal/mol), clemaphenol A (-7.3 kcal/mol), pectolinarigenin (-7.2 kcal/mol), leucocyanidin (-7.2 kcal/mol), and 28-acetyl botulin (-7.2 kcal/mol) from ayurvedic medicinal plants phytochemicals possess greater affinity than the reference standard Molnupiravir (-7.0 kcal/mol) against SARS-CoV-2-M<sup>pro</sup>.</p><p><strong>Conclusion: </strong>Two molecules, namely sennoside-B, and isotrilobine with low binding energies, were predicted as most promising. Furthermore, we carried out molecular dynamics simulations for the sennoside-B protein complexes based on the docking score. ADMET properties prediction confirmed that the selected docked phytochemicals were optimal. These compounds can be investigated further and utilized as a parent core molecule to create novel lead molecules for preventing COVID-19.</p>\",\"PeriodicalId\":18382,\"journal\":{\"name\":\"Medicinal Chemistry\",\"volume\":\"19 9\",\"pages\":\"925-938\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2174/1573406419666230413112802\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/1573406419666230413112802","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:自2019年11月疫情开始以来,已经发现了数量有限的抗SARS-CoV-2小分子。传统的药物化学方法需要一年中的十多年艰苦的研究和开发以及大量的财政承诺,面对当前的流行病,这是无法实现的。目的:通过对5种不同阿育吠德药用植物中39种植物化学物质的计算筛选,发现并识别与SARS-CoV-2 Mpro靶点相互作用最有效、最有前景的小分子。方法:从结构生物信息学研究合作实验室(RCSB)蛋白质数据库(PDB) PubChem下载植物化学物质,并将SARS-CoV-2蛋白(PDB ID: 6LU7;Mpro)取自PDB。分析了分子间相互作用、结合能和ADMET性质。结果:采用基于结构的分子对接药物设计研究结合亲和力,发现21个分子对靶标的亲和力大于或等于参比标准品。分子对接分析鉴定出13种植物化学物质:参叶皂苷b(-9.5千卡/mol)、异三叶合宾(-9.4千卡/mol)、三叶合宾(-9.0千卡/mol)、serratagenic acid(-8.1千卡/mol)、fistulin(-8.0千卡/mol)、friedelin(-7.9千卡/mol)、齐果酸(-7.9千卡/mol)、肉桂酮(-7.8千卡/mol)、3,4-二- o -咖啡酰奎宁酸(-7.4千卡/mol)、clemaphenol A(-7.3千卡/mol)、pectolinarigenin(-7.2千卡/mol)、leucocyanidin(-7.2千卡/mol)、与对照品Molnupiravir (-7.0 kcal/mol)相比,阿育吠陀药用植物中的28-乙酰肉毒素(-7.2 kcal/mol)对SARS-CoV-2-Mpro具有更强的亲和力。结论:sennoside-B和isotrilobine这两个低结合能的分子被认为是最有希望的。此外,我们基于对接评分对sennoside-B蛋白复合物进行了分子动力学模拟。ADMET性质预测证实了所选择的对接植物化学物质是最优的。这些化合物可以进一步研究,并用作母体核心分子,以创建预防COVID-19的新型先导分子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 Mpro Target.

Background: A limited number of small molecules against SARS-CoV-2 has been discovered since the epidemic commenced in November 2019. The conventional medicinal chemistry approach demands more than a decade of the year of laborious research and development and a substantial financial commitment, which is not achievable in the face of the current epidemic.

Objective: This study aims to discover and recognize the most effective and promising small molecules by interacting SARS-CoV-2 Mpro target through computational screening of 39 phytochemicals from five different Ayurvedic medicinal plants.

Methods: The phytochemicals were downloaded from Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) PubChem, and the SARS-CoV-2 protein (PDB ID: 6LU7; Mpro) was taken from the PDB. The molecular interactions, binding energy, and ADMET properties were analyzed.

Results: The binding affinities were studied using a structure-based drug design of molecular docking, divulging 21 molecules possessing greater to equal affinity towards the target than the reference standard. Molecular docking analysis identified 13 phytochemicals, sennoside-B (-9.5 kcal/mol), isotrilobine (-9.4 kcal/mol), trilobine (-9.0 kcal/mol), serratagenic acid (-8.1 kcal/mol), fistulin (-8.0 kcal/mol), friedelin (-7.9 kcal/mol), oleanolic acid (-7.9 kcal/mol), uncinatone (-7.8 kcal/mol), 3,4-di- O-caffeoylquinic acid (-7.4 kcal/mol), clemaphenol A (-7.3 kcal/mol), pectolinarigenin (-7.2 kcal/mol), leucocyanidin (-7.2 kcal/mol), and 28-acetyl botulin (-7.2 kcal/mol) from ayurvedic medicinal plants phytochemicals possess greater affinity than the reference standard Molnupiravir (-7.0 kcal/mol) against SARS-CoV-2-Mpro.

Conclusion: Two molecules, namely sennoside-B, and isotrilobine with low binding energies, were predicted as most promising. Furthermore, we carried out molecular dynamics simulations for the sennoside-B protein complexes based on the docking score. ADMET properties prediction confirmed that the selected docked phytochemicals were optimal. These compounds can be investigated further and utilized as a parent core molecule to create novel lead molecules for preventing COVID-19.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Medicinal Chemistry
Medicinal Chemistry 医学-医药化学
CiteScore
4.30
自引率
4.30%
发文量
109
审稿时长
12 months
期刊介绍: Aims & Scope Medicinal Chemistry a peer-reviewed journal, aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design. The journal publishes original research, mini-review articles and guest edited thematic issues covering recent research and developments in the field. Articles are published rapidly by taking full advantage of Internet technology for both the submission and peer review of manuscripts. Medicinal Chemistry is an essential journal for all involved in drug design and discovery.
期刊最新文献
In Silico Studies of Phytoconstituents to Identify Potential Inhibitors for ERα Protein of Breast Cancer A Preclinical Study on 4-Methyl-N-((4-(trifluoromethoxy)phenyl) carbamoyl)-benzenesulfonamide as a Potent Chemotherapeutic Agent against Liver and Pancreatic Carcinogenesis in Rats: Immunohistochemical and Histopathological Studies Exploring the Diverse Therapeutic Applications of 1, 3-Thiazine: A Comprehensive Review Unveiling the Anti-cancer Potential of Oxadiazole Derivatives: A Comprehensive Exploration of Structure-Activity Relationships and Chemico-Biological Insights Recent Advances in Anticancer Research of Osmium and Rhodium Complexes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1